| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0034 | 0.9 |